Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virgil Alfaro

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Diabetes Reviews|February 10, 2009
Ranibizumab for diabetic retinopathyMonica Rodriguez-Fontal, Virgil Alfaro, John B Kerrison, et al.
Current Diabetes Reviews|February 10, 2009
Metabolic control and diabetic retinopathyMonica Rodriguez-Fontal, John B Kerrison, D Virgil Alfaro, et al.
Ophthalmology Clinics of North America|November 30, 2005
Anti-macular degeneration agentsMichelle Rothen, Eric Jablon, Gerardo Monares, et al.
Current Diabetes Reviews|February 10, 2009
Diabetic retinopathy and angiogenesisTalia N Crawford, D Virgil Alfaro, John B Kerrison, et al.
Current Diabetes Reviews|January 29, 2008
Intravitreal triamcinolone for the treatment of diabetic macular edemaFrancisco Gómez-Ulla, Joaquín Marticorena, D Virgil Alfaro, et al.
Retinal Cases & Brief Reports|November 13, 2014
Functional and anatomical outcomes for intravitreal bevacizumab treatment of choroidal neovascularization in a patient with angioid streaksReinaldo A Garcia, Eric P Jablon, Veronica Oria, et al.
American Journal of Ophthalmology|March 16, 2005
Fishing-related ocular traumaD Virgil Alfaro, Eric P Jablon, Monica Rodriguez Fontal, et al.
Retinal Cases & Brief Reports|May 21, 2020
STELLATE UNILATERAL NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: A MULTIMODAL IMAGING ANALYSIS AND CASE REPORTMargarita Montano, D Virgil Alfaro, Miguel A Quiroz-Reyes, et al.
Expert Opinion on Biological Therapy|May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trialSusan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 26, 2026
MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic RetinopathyAvery W Zhou, Ryan A Sahraravand, Liisa M Baumann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Diabetes Reviews|February 10, 2009
Ranibizumab for diabetic retinopathyMonica Rodriguez-Fontal, Virgil Alfaro, John B Kerrison, et al.
Current Diabetes Reviews|February 10, 2009
Metabolic control and diabetic retinopathyMonica Rodriguez-Fontal, John B Kerrison, D Virgil Alfaro, et al.
Ophthalmology Clinics of North America|November 30, 2005
Anti-macular degeneration agentsMichelle Rothen, Eric Jablon, Gerardo Monares, et al.
Current Diabetes Reviews|February 10, 2009
Diabetic retinopathy and angiogenesisTalia N Crawford, D Virgil Alfaro, John B Kerrison, et al.
Current Diabetes Reviews|January 29, 2008
Intravitreal triamcinolone for the treatment of diabetic macular edemaFrancisco Gómez-Ulla, Joaquín Marticorena, D Virgil Alfaro, et al.
Retinal Cases & Brief Reports|November 13, 2014
Functional and anatomical outcomes for intravitreal bevacizumab treatment of choroidal neovascularization in a patient with angioid streaksReinaldo A Garcia, Eric P Jablon, Veronica Oria, et al.
American Journal of Ophthalmology|March 16, 2005
Fishing-related ocular traumaD Virgil Alfaro, Eric P Jablon, Monica Rodriguez Fontal, et al.
Retinal Cases & Brief Reports|May 21, 2020
STELLATE UNILATERAL NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: A MULTIMODAL IMAGING ANALYSIS AND CASE REPORTMargarita Montano, D Virgil Alfaro, Miguel A Quiroz-Reyes, et al.
Expert Opinion on Biological Therapy|May 8, 2026
Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III insight randomized clinical trialSusan B Bressler, Piotr Oleksy, Daniel Virgil Alfaro, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 26, 2026
MAGIC: Study Design and Rationale for the Phase 2 Clinical Trial of Faricimab for Non-Proliferative Diabetic RetinopathyAvery W Zhou, Ryan A Sahraravand, Liisa M Baumann, et al.
Pageof 1